Bank Julius Baer & Co. Ltd Zurich Has $1.31 Million Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Bank Julius Baer & Co. Ltd Zurich raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 13,154 shares of the exchange traded fund’s stock after purchasing an additional 487 shares during the period. Bank Julius Baer & Co. Ltd Zurich’s holdings in SPDR S&P Biotech ETF were worth $1,307,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $29,000. Golden State Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $29,000. Avior Wealth Management LLC boosted its stake in SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the last quarter. Tidemark LLC boosted its stake in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the last quarter. Finally, Bank of Jackson Hole Trust purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $43,000.

SPDR S&P Biotech ETF Stock Up 0.3 %

Shares of NYSEARCA XBI opened at $87.30 on Monday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The stock’s 50 day moving average price is $90.49 and its 200-day moving average price is $95.29. The company has a market capitalization of $5.76 billion, a PE ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.